Partners
LumaCyte
Lead Partner
LumaCyte is an advanced bioanalytics company that produces label-free, single cell analysis instrumentation where the use of antibody or genetic labeling is not required. This revolutionary technology utilizes Laser Force Cytology™ (LFC™) to measure the intrinsic biochemical and biophysical properties of each cell. Key applications of the technology include cell bank characterization and management, cell health monitoring, viral infectivity for vaccines and cell and gene therapy, in addition to multiple applications across the biomanufacturing sector for process optimization and quality control.
InProcess-LSP
Exhibition Partner
InProcess-LSP is a highly innovative organization providing full Process Analytical Technology (PAT) method and instrument development services. It was founded in 2014 and is based at Pivot Park High Tech Pharma campus in The Netherlands. Being experts in nanoparticle size characterization, they are the inventors of the NanoFlowSizer: a unique, non-invasive nanoparticle size instrumentation for real-time measurement. Nanoparticle sizing takes place within seconds, enabling continuous real-time in flow analysis. The NanoFlowSizer is the only instrument capable of measuring particle size and size distribution of turbid nanosuspensions in flow, without the need for sample treatment.
Bruker
Event Partner
As a global leader in analytical instrumentation, Bruker provides a comprehensive portfolio of PAT solutions—including software, instruments, and robotics—for drug discovery, biopharmaceutical characterization, and pharmaceutical quality control. Leveraging its broad expertise and diverse product lines across multiple scientific disciplines, Bruker is uniquely positioned to deliver complete, integrated PAT solutions tailored to the complex needs of the pharmaceutical industry. Our high-performance PAT tools enhance productivity, ensure superior data quality, and enable efficient, automated workflows. Committed to advancing pharmaceutical innovation, Bruker helps accelerate time-to-market and supports the development of safe, effective therapies for patients worldwide.